Education
About Us
Working with TipRanks
Follow Us
Cassava Sciences (SAVA)
NASDAQ:SAVA
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ -1.80K | $ 0.00 | $ 0.00 |
| Gross Profit | $ -1.13M | $ -89.42M | $ -1.30M | $ -534.00K | $ -346.00K |
| Operating Income | $ -151.35M | $ -105.96M | $ -80.02M | $ -32.87M | $ -6.45M |
| EBITDA | $ -23.21M | $ -95.69M | $ -74.94M | $ -31.85M | $ -6.31M |
| Net Income | $ -24.34M | $ -97.22M | $ -72.47M | $ -31.80M | $ -5.85M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 128.57M | $ 121.14M | $ 201.01M | $ 233.44M | $ 93.51M |
| Total Assets | $ 157.53M | $ 151.66M | $ 234.83M | $ 266.78M | $ 94.30M |
| Total Debt | $ 0.00 | $ 0.00 | $ 139.00K | $ 236.00K | $ 293.00K |
| Net Debt | $ -128.57M | $ -121.14M | $ -200.88M | $ -233.20M | $ -93.21M |
| Total Liabilities | $ 11.83M | $ 14.20M | $ 7.29M | $ 12.87M | $ 2.10M |
| Stockholders' Equity | $ 145.70M | $ 137.47M | $ 227.54M | $ 253.91M | $ 92.20M |
| Cash Flow | |||||
| Free Cash Flow | $ -117.03M | $ -82.44M | $ -80.23M | $ -52.41M | $ -5.38M |
| Operating Cash Flow | $ -116.93M | $ -82.03M | $ -77.51M | $ -30.20M | $ -5.38M |
| Investing Cash Flow | $ -103.00K | $ -414.00K | $ -2.71M | $ -22.21M | $ 360.00K |
| Financing Cash Flow | $ 124.47M | $ 2.56M | $ 47.80M | $ 192.34M | $ 75.45M |